Adagene Inc.

Last updated September 27, 2026

Organization details

Legal name
Adagene Inc.
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
2834 — Pharmaceutical Preparations
Jurisdiction of incorporation
Cayman Islands
Headquarters city
Jiangsu
Headquarters country
China
Fiscal year end
December
Ticker symbol
ADAG
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001818838

Board of directors

Chief executives

Peter Luo · Chief Executive Officer
Since March 2026

Board connections

1 of this board's directors also sit on 2 other boards. 1 is in the same sector.

Network of Adagene Inc.'s board connections BioVie Inc. BioVie Inc. Spark I Acquisition Corp. Spark I Acquisition Co... Cuong Do V Cuong Do V Adagene Inc.
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$162,258
5 purchases by 3 insiders
Sold, last 12 months
$0
0 sales by 0 insiders
Date Insider Transaction Shares Price Value
Sep 23, 2026 Man Kin Tam Director, Officer (Chief Financial Officer) Open-market purchase +2,000 $3.00 $6,000
Sep 16, 2026 Peter Luo Director, Officer (Chief Executive Officer) Open-market purchase +20,290 $3.15 $63,914
Aug 14, 2026 Cuong Do V Director Open-market purchase +2,000 $3.75 $7,500
Aug 5, 2026 Peter Luo Director, Officer (Chief Executive Officer) Open-market purchase +279 $3.65 $1,018
Aug 4, 2026 Peter Luo Director, Officer (Chief Executive Officer) Open-market purchase +22,966 $3.65 $83,826

Organizations in the same sector, closest in location and size first.

Questions about Adagene Inc.

Who is the CEO of Adagene Inc.?

Peter Luo has been Adagene Inc.'s Chief Executive Officer since March 2026.

How many directors are on Adagene Inc.'s board?

Adagene Inc.'s board has 6 directors: Andy Yiu Leung Cheung, Cuong Do V, Li Zhu, Man Kin Tam, Peter Luo and Ulf Grawunder.

Are Adagene Inc. insiders buying or selling shares?

Over the last 12 months, Adagene Inc. insiders bought $162,258 of shares in 5 purchases and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="adagene-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.